Literature DB >> 24740566

SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.

Hui Li1, Yang Peng, Huiyan Niu, Baogang Wu, Yi Zhang, Yue Zhang, Xue Bai, Ping He.   

Abstract

Sperm-associated antigen 9 (SPAG9) was recently reported to be overexpressed in several cancers and associated with the malignant behavior of cancer cells. However, the expression pattern of SPAG9 and its clinical significance in human prostate cancer have not been reported. In the present study, we analyzed SPAG9 expression in human prostate cancer tissues by immunohistochemistry and found that SPAG9 was overexpressed in 36.5 % of prostate cancer specimens. There was a significant association between SPAG9 overexpression and tumor stage (p = 0.0020) and Gleason score (p = 0.0377). Transfection of SPAG9 plasmid was performed in PC-3 cell line and siRNA knockdown was carried out in DU145 cells. Colony formation and MTT showed that SPAG9 overexpression promoted while siRNA knockdown inhibited prostate cancer cell proliferation. In addition, we found that SPAG9 could regulate cyclin D1 and cyclin E protein expression. In conclusion, SPAG9 is overexpressed in human prostate cancers and contributes to prostate cancer cell growth, possibly through cyclin protein regulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740566     DOI: 10.1007/s13277-014-1947-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.

Authors:  Deepika Kanojia; Manoj Garg; Samir Gupta; Anju Gupta; Anil Suri
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

2.  JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway.

Authors:  Kimia Kashef; Clement M Lee; Ji Hee Ha; E Premkumar Reddy; Danny N Dhanasekaran
Journal:  Biochemistry       Date:  2005-11-01       Impact factor: 3.162

3.  Promoter methylation profile of GSTP1 and RASSF1A in benign hyperplasia and metastatic prostate cancer patients in a Kashmiri population.

Authors:  Nidda Syeed; A Syed Sameer; Arif Hamid; Zafar A Shah; Dil Afroze; Roohi Rasool; Mushtaq A Siddiqi
Journal:  Mol Med Rep       Date:  2010-07-26       Impact factor: 2.952

4.  Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein.

Authors:  Kimia Kashef; Rangasudhagar Radhakrishnan; Clement M Lee; E Premkumar Reddy; Danny N Dhanasekaran
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

5.  The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells.

Authors:  Yang Liu; Liang Wang; Xu-Yong Lin; Jian Wang; Juan-Han Yu; Yuan Miao; En-Hua Wang
Journal:  Tumour Biol       Date:  2013-02-20

6.  The scaffold protein c-Jun NH2-terminal kinase-associated leucine zipper protein regulates cell migration through interaction with the G protein G(alpha 13).

Authors:  Davaakhuu Gantulga; Baljinnyam Tuvshintugs; Yoshio Endo; Takahisa Takino; Hiroshi Sato; Seishi Murakami; Katsuji Yoshioka
Journal:  J Biochem       Date:  2008-09-30       Impact factor: 3.387

7.  The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Authors:  Laura Vízkeleti; Szilvia Ecsedi; Zsuzsa Rákosy; Adrienn Orosz; Viktória Lázár; Gabriella Emri; Viktória Koroknai; Tímea Kiss; Róza Ádány; Margit Balázs
Journal:  Tumour Biol       Date:  2012-09-23

8.  Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.

Authors:  Manoj Garg; Deepika Kanojia; Sushma Suri; Anil Suri
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

9.  The cellular functions of RASSF1A and its inactivation in prostate cancer.

Authors:  Karishma S Amin; Partha P Banerjee
Journal:  J Carcinog       Date:  2012-02-17

10.  Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo.

Authors:  Giichi Takaesu; Jong-Sun Kang; Gyu-Un Bae; Min-Jeong Yi; Clement M Lee; E Premkumar Reddy; Robert S Krauss
Journal:  J Cell Biol       Date:  2006-10-30       Impact factor: 10.539

View more
  10 in total

1.  Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.

Authors:  Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Jian-Hua Wu; Xing-Yu Liu; Hao Xu; Yi You; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

Review 2.  Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges.

Authors:  Anil Suri; Nirmala Jagadish; Shikha Saini; Namita Gupta
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

3.  Sperm-associated antigen 9 is upregulated in hepatocellular carcinoma tissue and enhances QGY cell proliferation and invasion in vitro.

Authors:  Biqiong Ren; Guoying Zou; Junyu He; Yiran Huang; Guoan Ma; Guofeng Xu; Yong Li; Ping Yu
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

4.  SPAG9 is overexpressed in osteosarcoma, and regulates cell proliferation and invasion through regulation of JunD.

Authors:  Chi Xiao; Lin Fu; Chongnan Yan; Fenyong Shou; Qi Liu; Lei Li; Shaoqian Cui; Jingzhu Duan; Guoxin Jin; Jianhua Chen; Yuanming Bian; Xu Wang; Huan Wang
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

5.  SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.

Authors:  Chutian Xiao; Mingzhao Li; Qunxiong Huang; Jie Si-Tu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

6.  Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.

Authors:  Ali Jalali; E Susan Amirian; Matthew N Bainbridge; Georgina N Armstrong; Yanhong Liu; Spyros Tsavachidis; Shalini N Jhangiani; Sharon E Plon; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy
Journal:  Sci Rep       Date:  2015-02-05       Impact factor: 4.379

7.  miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9.

Authors:  Qin Hui Sun; Zong Xiu Yin; Zhi Li; Shu Bo Tian; Hong Chang Wang; Fang Xu Zhang; Le Ping Li; Chun Ning Zheng; Shuai Kong
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

8.  Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer.

Authors:  Biqiong Ren; Xiaobin Wei; Guoying Zou; Junyu He; Guofeng Xu; Fei Xu; Yiran Huang; Haowen Zhu; Yong Li; Guoan Ma; Ping Yu
Journal:  Oncol Rep       Date:  2016-03-01       Impact factor: 3.906

9.  Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.

Authors:  Ji Hee Ha; Mingda Yan; Rohini Gomathinayagam; Muralidharan Jayaraman; Sanam Husain; Jinsong Liu; Priyabrata Mukherjee; E Premkumar Reddy; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-11-08

10.  AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers

Authors:  Ameneh Tavakoli Koudehi; Bahar Mahjoubi; Rezvan Mirzaei; Samira Shabani; Frouzandeh Mahjoubi
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.